Risk factors of hepatocellular carcinoma recurrence after liver transplantation: Accuracy of the alpha-fetoprotein model in a single-center experience

Transplantation Proceedings

Volumn 47, Issue 1, 2015, Pages 84-89

  Varona, M A ^a   Soriano, A ^a   Aguirre Jaime, A ^a   Garrido, S ^a   Oton, E ^a   Diaz, D ^a   Portero, J ^b   Bravo, P ^a   Barrera, M A ^a   Perera, A ^a  

^a HOSPITAL UNIVERSITARIO NUESTRA SEÑORA DE CANDELARIA   (Spain)

^b Investigation Unit Hospital Universitario Nuestra Sra de Candelaria S/C de Tenerife ^*  (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN;

ADULT; AGED; BILE DUCT CARCINOMA; CANCER INFILTRATION; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CONFERENCE PAPER; DIABETES MELLITUS; FEMALE; FRENCH ALPHA FETOPROTEIN MODEL; GRAFT REJECTION; HOSPITALIZATION; HUMAN; HYPERTENSION; INFECTION; KIDNEY FAILURE; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROGNOSTIC ASSESSMENT; SURVIVAL RATE; TUMOR INVASION; BLOOD; CARCINOMA, HEPATOCELLULAR; COMPLICATION; DECISION SUPPORT SYSTEM; EVALUATION STUDY; LIVER NEOPLASMS; METABOLISM; MIDDLE AGED; MORTALITY; NEOPLASM RECURRENCE, LOCAL; PATHOLOGY; PATIENT SELECTION; PROGNOSIS; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR;

ADULT; AGED; ALPHA-FETOPROTEINS; CARCINOMA, HEPATOCELLULAR; DECISION SUPPORT TECHNIQUES; FEMALE; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PATIENT SELECTION; PROGNOSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS;

EID: 84923233623     PISSN: 00411345     EISSN: 18732623     Source Type: Journal    
DOI: 10.1016/j.transproceed.2014.12.013     Document Type: Conference Paper

References (19)

1. European Association for the Study of the Liver European Organisation for Research and Treatment of Cancer EASL-EORTC Clinical Practice Guidelines: Management of Hepatocellular Carcinoma J Hepatol 56 2012 908 943
2. P. Clavien, M. Lesurtel, P. Bossuyt on behalf of the OLT for HCC Concensus Group Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference report Lancet Oncol 13 2012 e11 e22
3. A. Forner, J. Llovet, and J. Bruix Hepatocellular carcinoma Lancet 379 2012 1245 1255
4. C. Verslype, O. Rosmorduc, P. Rougier on behalf of the ESMO Guidelines Working Group Hepatocellular carcinoma: ESMO-ESDO clinical practice guidelines for diagnosis, treatment and follow-up Ann Oncol 23 Suppl 7 2012 vii41 vii48
5. L. De Carlis, S. Di Sandro, and A. Giacomoni Beyond the Milan Criteria: what risks for patients with hepatocellular carcinoma progression before liver transplantation? J Clin Gastroenterol 46 2012 78 86
6. M.E. Schwartz, F. D'Amico, and A. Vitale Liver transplantation for hepatocellular carcinoma: are the Milan criteria still valid? Eur J Surg Onol 34 2008 256 262
7. V. Mazzaferro, S. Bhoori, and C. Spositio Milan criteria in liver transplantation for hepatocellular carcinoma: an evidence-based analysis of 15 years of experience Liver Transpl 17 2011 S44 S57
8. F.Y. Yao, L. Ferrell, and N.M. Bass Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival Hepatology 33 2001 1394 1403
9. C. Duvoux, F. Roudot-Thoraval, and T. Decaens Liver transplantation for hepatocellular carcinoma: a model including α-fetoprotein improves the performance of Milan criteria Gastroenterology 143 2012 986 994
10. K. Berry, and G. Loannou Serum alpha-fetoprotein level independently predicts posttransplant survival in patients with hepatocellular carcinoma Liver Transpl 19 2013 634 645
11. C. Tosso, S. Asthana, and D. Bigam Reassesing selection criteria prior to liver transplantation for hepatocellular carcinoma utilizing the scientific registry of transplant recipients database Hepatology 49 2009 832 838
12. O. Yaprak, M. Akyildiz, and M. Dayangac AFP level and histologic differentiation predict the survival of patients with liver transplantation for hepatocellular carcinoma Hepatobiliary Pancreat Dis Int 11 2012 256 261
13. S.H. Yang, K.S. Suh, and H.W. Lee A revised scoring system utilizing serum alphafetoprotein levels to expand candidates for living donor transplantation in hepatocellular carcinoma Surgery 141 2007 598 609
14. X. Xu, Q. Ke, and Z. Shao The value of serum α-fetoprotein in predicting tumor recurrence after liver transplantation for hepatocellular carcinoma Dig Dis Sci 54 2009 385 388
15. A. Notarpaolo, G. Bizouard, and M. Gambato Prediction of recurrence after liver transplantation for HCC: validation of the AFP model in a Italian cohort Liver Transpl 20 Suppl 1 2014 S132
16. K. Chan, H. Chou, and T. Wu Characterization of hepatocellular carcinoma recurrence after liver transplantation: perioperative prognostic factors, patterns, and outcome Asian J Surg 34 2011 128 134
17. S. Jonas, W. Bedstein, and T. Steinmuller Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis Hepatology 33 2001 1080 1086
18. S.U. Zheng, X. Xu, and J. Wu Liver transplantation for hepatocellular carcinoma: Hangzhou experience Transplantation 85 2008 1726 1732
19. P.E. Majno, R. Lencioni, and F. Mornex Is treatment of HCC on the waiting list necessary Liver Transpl 17 2011 S98 S108